Cutaneous B‐cell lymphoma: Pathological spectrum and clinical outcome in 51 consecutive patients
Anuraag Sah(Leeds General Infirmary), Roger G. Owen(Leeds Teaching Hospitals NHS Trust)
Cited by 23
Related Papers
High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma
|New England Journal of Medicine|2003|1.8k
Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2008|605
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial
|The Lancet|2010|571
Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study
|Journal of Clinical Oncology|2013|419
Guidelines for the diagnosis and management of multiple myeloma 2011
|British Journal of Haematology|2011|305